International Patent: 7-FLUORO-5-METHOXY-2,3-DIHYDRO-[1,3]OXAZINO[4,5,6-DE]QUINAZOLINE DERIVATIVES AS RAS G12D INHIBITORS FOR THE TREATMENT OF CANCER

GENEVA, July 27 -- ASTRAZENECA AB filed a patent application (EP2026/050977) for “7-FLUORO-5-METHOXY-2,3-DIHYDRO-[1,3]OXAZINO[4,5,6-DE]QUINAZOLINE DERIVATIVES AS RAS G12D INHIBITORS FOR THE TREATMENT OF CANCER”. With publication no. WO/2026/154081, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 498/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....